CNN-based arrhythmia classifier that fuses the magnitude (scalogram) and phase (phasogram) of the continuous wavelet transform (CWT) of ECG heartbeats, rather than relying on magnitude information alone as most prior 2D-representation approaches do. Several fusion strategies (input-level, intermediate-layer, and output-level fusion) were compared on the public PhysioNet MIT-BIH Arrhythmia database. Despite a simple CNN architecture, the best fusion strategy achieved about 98.5% overall accuracy, 98.5% sensitivity and 95.6% specificity, competitive with more complex state-of-the-art approaches.

Regression-based convolutional neural network that directly estimates the heart-rate-corrected QT interval (QTc) from a 12-lead ECG, aiming to improve on automated QTc measurements from commercial ECG systems, which often diverge from expert readings. QTcNet was trained on 120,300 algorithm-labeled ECGs from an internal hospital cohort and the public MIMIC-IV database (after correcting for a vendor-specific measurement bias), and evaluated against expert QTc measurements in three independent external cohorts (PTB Diagnostic ECG Database, QTcMS, and ECGRDVQ). It roughly halved the mean absolute error compared with standard ECG analysis software (from 23.4ms to 13.4ms across external validation cohorts), with explainability analysis confirming the model focuses on physiologically plausible QRS-onset and T-offset regions.

Multi-outcome AI-ECG risk-estimation platform that turns a single 12-lead ECG into a patient-specific survival curve, using a residual convolutional neural network trained with a discrete-time survival loss to predict not just risk but time-to-event. Beyond all-cause and cardiovascular mortality, separately fine-tuned heads predict future ventricular arrhythmia, complete heart block, atrial fibrillation, atherosclerotic cardiovascular disease, heart failure, and (in follow-up work) hypertension -- all from a single resting ECG, including in ECGs a cardiologist would read as normal. Derived on 1.16 million ECGs from 189,539 Beth Israel Deaconess Medical Center patients and externally validated across transnational cohorts in the USA, Brazil (CODE), and the UK (UK Biobank). A variational autoencoder and genome/phenome-wide association analyses were used to show the model's predictions track biologically plausible features (QRS morphology, LV structure/function, and loci linked to cardiac structure, QT interval, and biological aging). NHS trials of AIRE were planned for late 2025. No public code or model weights have been released.

Supervised EfficientNetV2-based 12-lead ECG model trained on over 1 million ECGs from the Montreal Heart Institute to predict 77 cardiac conditions derived from American Heart Association recommendations, plus fine-tuned digital-biomarker heads for reduced LVEF, 5-year atrial-fibrillation risk, and long-QT-syndrome (LQTS) detection/genotyping. Validated on 881,403 ECGs across 11 geographically diverse cohorts (4 public, 7 private health systems), achieving AUROCs above 0.98 for the 77-condition interpretation task while being 60x smaller and 29x faster at inference than its self-supervised DeepECG-SSL counterpart, with up to 9.7x lower CO2 emissions on equivalent tasks.

Self-supervised EfficientNetV2-based 12-lead ECG foundation model pretrained via contrastive learning and masked-lead modeling on 1.9 million ECGs (Montreal Heart Institute plus CODE-15% and MIMIC-IV), then fine-tuned for the same 77-condition ECG interpretation task and digital-biomarker extraction as DeepECG-SL. Outperforms the supervised counterpart on label-scarce digital-biomarker tasks, with the largest gains on LQTS genotype classification (AUROC 0.931 vs. 0.850, n=127 ECGs) and 5-year atrial-fibrillation risk (AUROC 0.742 vs. 0.734, n=132,050 ECGs), and outperforms ECG-FM and ECGFounder on shared external diagnostic classes.

Explainable Inception-style 1D CNN for multi-label arrhythmia detection from 12-lead ECGs, integrating Grad-CAM visualization to highlight the waveform segments driving each prediction. Trained on MIMIC-IV-ECG and externally validated on PTB-XL across atrial fibrillation, sinus tachycardia, conduction disturbances (RBBB/LBBB/LAFB), long QT, Wolff-Parkinson-White pattern, and paced-rhythm detection, with all metrics exceeding 90% internally and strong generalization on external validation.

ECG foundation model designed to remain accurate when leads are missing or signals are noisy. A 1D ConvNeXt V2 encoder is trained with a dual-mode self-distillation objective (separate lead-missing and noise "teachers") alongside contrastive alignment to detailed diagnostic-criteria text reports retrieved via a lightweight, LLM-free "Cardiac Feature Retrieval" module. Consistently ranks best or second-best across PTB-XL diagnostic tasks and MIT-BIH arrhythmia classification under original, noisy, lead-missing, and combined-corruption conditions. Developed by FPT Software AI Center and the University of Arkansas.

Multi-task 12-lead ECG model with output heads for incident atrial-fibrillation risk (as a survival curve), incident mortality risk, prevalent AF classification, sex classification, and age regression. Built on a 1D CNN over the raw waveform, and developed by the Broad Institute's ML4H group as a successor to their ECG-AI model published in Circulation. Trained on ECGs from UK Biobank and Massachusetts General Hospital, neither of which is publicly released.